Abstract：OBJECTIVE: To study the effects of budesonide on hypoxia inducible factor 1α(HIF-1α) and vascular endothelial growth factor (VEGF) expression, angiogenesis and airway remodeling in the chronic asthmatic mouse model. METHODS: Thirty female BALB/c mice were randomly divided into normal control, asthma model and treatment groups (10 in each group).The asthmatic mouse model was established via OVA challenge test. Mice in the treatment group were administered with aerosol budesonide (100 μg/kg) an hour before the OVA challenge test from the 28th day. Mice in the control group were treated with PBS instead of OVA. Hematoxylin and eosin staining was performed to observe thickness of the airway wall. Masson staining was used for examing collagen deposition of lung tissues. Angiogenesis and HIF-1α and VEGF expression were measured using immunohistochemistry and Western blot. The relationship of airway wall thickness and vessel area to HIF-1α and VEGF expression was investigated. RESULTS: Vessel area, collagen deposition of lung tissues and airway wall thickness increased in the asthma model group. Levels of HIF-1α and VEGF were also elevated. Administration of budesonide significantly reduced angiogenesis, collagen deposition of lung tissues and airway wall thickening, as well as expression of HIF-1α and VEGF. The vessel area and airway wall thickness were positively correlated with expression of HIF-1α and VEGF. A positive correlation was also found between the expression of HIF-1α and VEGF. CONCLUSIONS: Budesonide can decease angiogenesis and airway remodeling by inhibiting HIF-1α and VEGF expression in asthmatic mice.
SUN Yan,WANG Jin-Rong,HAN Xiu-Zhen et al. Effects of budesonide on HIF-1α and VEGF expression and airway remodeling in an asthmatic mouse model[J]. CJCP, 2012, 14(08): 622-627.
［1］Lee SY, Kwon S, Kim KH, Moon HS, Song JS, Park SH, et al. Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients［J］. Ann Allergy Asthma Immunol, 2006, 97(6): 794-799.
［3］Yu P, Kodadek T. Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex ［J］. J Biol Chem, 2007, 282 (48): 35035-35045.
［4］Kim SR, Lee KS, Park SJ, Min KH, Choe YH, Moon H, et al. Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease［J］. J Allergy Clin Immunol, 2010, 125(2): 449-460.
［5］Yamaguchi M, Niimi A, Matsumoto H, Ueda T, Takemura M, Matsuoka H, et al. Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findings［J］. J Investig Allergol Clin Immunol, 2008,18(3): 202-206.
［6］Hoshino M, Aoike N, Takahashi M, Nakamura Y, Nakagawa T. Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma［J］. Eur Respir J, 2003, 21(5): 804-809.
［7］Baluk P, Lee CG, Link H, Ator E, Haskell A, Elias JA, et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways［J］. Am J Pathol, 2004,165 (4): 1071-1085.
［8］Yuksel H, Kose C, Yilmaz O, Ozbilgin K, Degirmenci PB, Pinar E, et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component［J］. Clin Exp Allergy, 2007,37(8): 1183-1188.
［9］Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma［J］. Allergy, 2010,65(8):946-958.
［11］Chetta A, Zanini A, Foresi A, D′Ippolito R, Tipa A, Castagnaro A, et al.Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma［J］. Clin Exp Allergy, 2005, 35(11): 1437-1442.
［12］Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, Krymskaya VP, Lazaar AL. Vascular endothelial gronth factor-induced secretion of fibronectin is ERK depenolent［J］. Am J Physiol Lung Cell Mol Physiol, 2004, 286(3): L539-L545.
［13］Kaelin WG Jr. How oxygen makes its presence felt［J］. Genes Dev, 2002, 16 (12): 1441-1445.
［14］Hellwig-Bürgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions［J］. J Interferon Cytokine Res, 2005, 25(6): 297-310.
［15］Hasaneen NA, Zucker S, Cao J, Chiarelli C, Panettieri RA, Foda HD.Cyclic mechanical strain-induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs［J］. FASEB J, 2005, 19(11): 1507-1509.
［16］Liu LZ, Jing Y, Jiang LL, Jiang XE, Jiang Y, Rojanasakul Y, et al.Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1 α pathway［J］. Biochem Biophys Res Commun, 2011, 413(2): 299305.
［17］Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1［J］. Circ Res, 2003, 93(11): 1074-1081.
［18］Korideck H, Peterson JD. Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma［J］. J Pharmacol Exp Ther, 2009, 329(3): 882889.
